Clinical Trial Update: Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating SNS-301 in combination with checkpoint inhibitors for metastatic/recurrent squamous cell carcinoma of the head and neck; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• SNS-301 (SNS-301)

Snippet

Sponsor: Sensei Biotherapeutics, Inc. | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-12-30